UNSPSC 85892121: High dose rate (hdr) brachytherapy of nasopharynx using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of nasopharynx using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D91D9BZ

UNSPSC 85892121 High dose rate (HDR) brachytherapy of nasopharynx using palladium 103 (Pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity in the dataset tagged to this code — County of Santa Clara Health System's solicitation for temporary health professional staffing services across ancillary clinical categories (RFSQHHSFY270052, RFQ response due October 7, 2026) — addresses temporary clinical staffing in audiology, radiology, therapy, sterile processing, and related non-physician roles, which falls outside the narrow scope of a specialized brachytherapy procedure for nasopharyngeal cancer treatment. The mismatch between the code's technical specificity and the staffing-focused opportunity suggests a tagging inconsistency rather than genuine procurement demand under this code.

State and local health systems do procure oncology services and radiation therapy, but not typically through RFQ vehicles for qualified vendor pools in this manner. The absence of additional opportunities in the recent record and the categorical mismatch in the single posted opportunity indicate minimal or no active solicitation activity under this code. Firms pursuing state and local health-system contracts in radiation oncology or brachytherapy should monitor broader clinical services codes and direct engagement with county and municipal health departments rather than rely on recent activity under this code.